-
Mashup Score: 2
The Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky’s, MD, endorsement Thursday evening came after 2 days of deliberation from the CDC’s Advisory Committee on Immunization Practices (ACIP) where the group recommended the Moderna and Janssen COVID-19 vaccine “booster” doses.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0
The White House said it has secured enough of the Pfizer-BioNTech vaccine supply to offer vaccinations for everyone in this age group.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#Breaking The White House said it has secured enough of the #PfizerBioNTech #vaccine supply to offer vaccinations for everyone in this age group. #COVID19 https://t.co/BrAUKChZQd
-
-
Mashup Score: 0
US federal health agencies are recommending an additional shot for this diverse patient population, and here on some insights about vaccine efficacy and breakthrough infections in these groups.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#Qatar has one of the highest #vaccination rates in the world, but the waning efficacy of the #Pfizervaccine is leading to breakthrough infections. #COVID19 #vaccinationupdate #PfizerBiontech https://t.co/329EFahFE2
-
-
Mashup Score: 25Pfizer-BioNTech COVID-19 Vaccine in 5-11 Year Olds Found Safe, Elicits Immune Response - 3 year(s) ago
A smaller dosage was used and with their results the two companies plan to submit their data to governmental regulatory agencies around the world.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
A smaller dosage was used, and with their results, #PfizerBiontech plan to submit their data to governmental regulatory agencies around the world for their #COVID19 #vaccine https://t.co/TRNF96si9T
-
-
Mashup Score: 1FDA Meeting Today to Discuss Booster Doses - 3 year(s) ago
A Food and Drug Administration (FDA) committee will discuss this topic as it pertains to the potential approval of a third dose of the Pfizer-BioNTech COVID-19 vaccine. The results of this meeting could have ramifications for the Biden Administration’s COVID-19 health policy.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#FDA is meeting to discuss the potential approval of #Booster doses of the #PfizerBioNTech #COVID19 #vaccine and the results of this meeting could have implications for the Biden Administration’s COVID-19 health policy. https://t.co/EkujKz8F90
-
-
Mashup Score: 1mRNA Vaccines Against SARS-CoV-2 Differ in Antibody Response - 3 year(s) ago
Pfizer-BioNTech and Moderna mRNA vaccines provoke different levels of antibody response within and between age groups.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
Head-to-head evaluation of #PfizerBiontech and #Moderna #mRNA #COVID19 #vaccines revealed different levels of antibody response https://t.co/ONs7ijSjEL
-
-
Mashup Score: 716
The decision will set off a cascade of vaccine requirements by hospitals, colleges, corporations, and some state and local governments.
Source: www.nytimes.comCategories: Infectious Disease, Latest HeadlinesTweet-
So glad that the @US_FDA finally granted full approval of the #PfizerBioNtech #vaccine I am not sure full approval will sway those not already been #vaccinated but I do hope it will make employers and businesses feel comfortable mandating it https://t.co/Fm25h2iHUm
-
The problem is that by excluding the 12-15 yr from full approval, school mandates for middle schools may be out the window, and advocacy for bumping up the awful low vaccination rates for this age group in the South (now at only 25-30%) now even tougher https://t.co/njZrV5U7hV
-
This morning, FDA granted full approval to Pfizer-BioNTech’s coronavirus vaccine for people 16 and up, making it the first to move beyond emergency use status in the United States. https://t.co/QhTMMRX3js
-
-
Mashup Score: 1Public Health Watch: New CDC Data Suggests Pfizer-BioNTech Vaccine Is Safe in Adolescents - 3 year(s) ago
Fewer than 10,000 adverse events among more than 8.9 million doses administered.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
Of the more than 8.9 million doses of the #pfizerbiontech #COVID19 #vaccines administered, fewer than 10,000 adverse events occurred and of them only 890 cases were considered serious. https://t.co/0T5xNyyD5M
-
-
Mashup Score: 0
The Food and Drug Administration (FDA) is expected to expand the Emergency Use Authorization (EUA) of the Pfizer-BioNTech and Moderna vaccines for a third dose in those who might be vulnerable to COVID-19.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
The #FDA is expected to expand the Emergency Use Authorization of the #PfizerBiontech and #Moderna #vaccines for a third dose in those who might be vulnerable to #COVID19 https://t.co/qxLJFU1z8u
-
-
Mashup Score: 3mRNA vaccines reduce risk of infection by 91% - 3 year(s) ago
A recent analysis of CDC data concludes that vaccinated people who do get COVID-19 experience more mild illness and are sick for less time.
Source: www.medicalnewstoday.comCategories: General Medicine News, Latest HeadlinesTweet-
The @CDCgov outlines the latest findings from the HEROES-RECOVER study. The study is one of the first to demonstrate that the #PfizerBioNTech and #Moderna #vaccines benefit people who get #COVID19 despite receiving full or partial vaccinations. https://t.co/w5C6VU7kCI
-
#ICYMI the #CDC Director endorsed the #moderna #Pfizerbiontech and #Janssen vaccines for #booster doses for eligible #Americans https://t.co/elA0RdiK7K